Diaceutics PLC (AIM:DXRX)
London
· Delayed Price · Currency is GBP · Price in GBX 146.00
0.00 (0.00%)
At close: Mar 6, 2026
Diaceutics Revenue
Diaceutics had revenue of 14.56M GBP in the half year ending June 30, 2025, with 46.76% growth. This brings the company's revenue in the last twelve months to 34.40M, up 31.83% year-over-year. In the year 2024, Diaceutics had annual revenue of 32.16M with 35.69% growth.
Revenue (ttm)
34.40M
Revenue Growth
+31.83%
P/S Ratio
3.60
Revenue / Employee
161.51K
Employees
213
Market Cap
123.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.16M | 8.46M | 35.69% |
| Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
| Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
| Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
| Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Tristel | 49.54M |
| Optima Health | 113.75M |
| Scancell Holdings | 4.71M |
| EKF Diagnostics Holdings | 50.22M |